Showing 11,821 - 11,840 results of 32,731 for search '(( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.08s Refine Results
  1. 11821
  2. 11822

    Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  3. 11823

    Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  4. 11824
  5. 11825
  6. 11826
  7. 11827

    Docking results of effective compounds in TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  8. 11828

    Active compounds screened from TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  9. 11829

    Network of compound-target-pathway. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  10. 11830
  11. 11831

    Identifying transcripts associated with the maturation of wild-type chondrocytes in pellet cultures. by Margot E. Bowen (224612)

    Published 2014
    “…D: Flow Chart showing the method used to define a set of transcripts that consistently decreased or increased in abundance over time in three independent experiments.…”
  12. 11832
  13. 11833

    Supplementary Material for: Endovascular thrombectomy with or without bridging thrombolysis in acute ischemic stroke: A cost-effectiveness analysis by Morsi R.Z. (17739816)

    Published 2024
    “…Background There is unclear added benefit of intravenous thrombolysis (IVT) with endovascular thrombectomy (EVT). We performed a cost-effectiveness analysis to assess the cost-effectiveness comparing EVT with IVT versus EVT alone. …”
  14. 11834

    Climate and seed size of a dry forest species: influence on seed production, physiological quality, and tolerance to abiotic stresses by Samara Elizabeth Vieira Gomes (4718994)

    Published 2023
    “…The predicted increase in temperature will not impair germination, however, the time available for seedling establishment will decrease due to lacking rainfall. The increase in the amount of small-sized seeds produced in drought years is a strategy for coping with harsh environments, rather than a decrease in seed quality.…”
  15. 11835

    Identification of AM251 as an EMT suppressing compound. by Tomoyo Yoshinaga (3391553)

    Published 2016
    “…Compounds that decreased the ratio of expression levels of <i>COL1A1</i> to <i>PPIA</i> to ≤50% compared with control (no compound, +TGF-β1; gray circles) were selected as hit compounds (red circles). …”
  16. 11836
  17. 11837

    Serum lipoxin A4 (LXA4) and resolvin D1 (RvD1) deficiency in patients with sleep-disordered breathing. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) Serum RvD1 and (B) LXA4 levels were both decreased in patients with primary snoring (PS), treatment-naïve OSA, and severe OSA on CPAP treatment as compared with that in the healthy subjects (HS). …”
  18. 11838

    Image_1_Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study.pdf by Qingran Yan (637573)

    Published 2023
    “…The CRR rate was 42.3% (11/26) at month 6. With a median follow-up of 52 weeks (range: 23-116 weeks), the CRR rate at the last visit was 50% (13/26) and 73.1% (19/26) of patients had UPCR decrease of over 50%. …”
  19. 11839
  20. 11840

    DtpT proteoliposomes require both a valid substrate and potential gradient in order to drive proton-coupled transport. by Imran Khan (109715)

    Published 2025
    “…(C) Validation of pyranine assays in DtpT liposomes. Curves show the mean of three replicates normalised to the initial fluorescence signal (t = -50 s). …”